Stock Track | JD Health Soars 5.01% Intraday on Strategic Partnership with Everest Medicines

Stock Track
07/16

JD Health's stock soared 5.01% during intraday trading on Thursday, reflecting significant investor interest.

The surge follows the announcement of a strategic cooperation agreement between JD Health and biopharmaceutical company Everest Medicines. The partnership will focus on innovative drug new product launches, patient services, digital marketing, and internet healthcare, with Everest Medicines prioritizing its new products on the JD Health platform to improve drug accessibility and service quality.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10